πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 230 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8012976

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8012493

Malaria vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7972821

Production of functional proteins: balance of shear stress and gravity

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration Β· Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7906555

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbala

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7897763

Process for the preparation of substituted phenylalanines

LEXICON PHARMACEUTICALS, INC. Β· Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7855291

Process for the preparation of substituted phenylalanines

LEXICON PHARMACEUTICALS, INC. Β· Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790433

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer usi

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7662607

Chalaropsis lysozyme protein and its method of use in anti-bacterial applications

New Century Pharmaceuticals, Inc. Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7655247

Malaria vaccines

The Government of the United States, as Respresented by the Secretary of the Army Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7591995

Cobalamin conjugates useful as imaging and therapeutic agents

Regents of the University of Minnesota Β· Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7585852

Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferati

Solidago AG Β· Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7560263

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer usi

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7553653

Variants and chemically-modified variants of phenylalanine ammonia-lyase

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7537923

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer usi

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7534595

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7531341

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7531162

Transcobalamin receptor binding conjugates useful for treating abnormal cellular prolifera

Regents of the University of Minnesota Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7468432

Cobalamin conjugates useful as antitumor agents

Regents of the University of Minnesota Β· Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7442558

Phthalamide-lanthanide complexes for use as luminescent markers

The Regents of the University of California Β· Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7417044

Tadalafil having a large particle size and a process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378273

Expression vectors

Gala Design, Inc. Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7374910

DNA encoding galanin receptor activating peptide

Takeda Pharmaceutical Company Limited Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7371571

Recombinant mycobacteria overexpressing D-alanine ligase gene and uses therefore

BOARD OF REGENTS UNIVERSITY OF NEBRASKA-LINCOLN Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7259167

Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds havi

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted